EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

A review of existing neonatal hyperbilirubinemia guidelines in Indonesia

Mahendra Tri Arif Sampurna iD, Danny Chandra Pratama, Visuddho Visuddho iD, Novita Oktaviana, Achmad Januar Er Putra, Rahmi Zakiyah, Jordy Maulana Ahmad, Risa Etika, Kartika Darma Handayani, Martono Tri Utomo, Dina Angelica, Wurry Ayuningtyas und 5 weitere

F1000Research · 2023

DOI: 10.12688/f1000research.110550.2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift F1000Research, 2023. Verfasst von Mahendra Tri Arif Sampurna und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neonatology Division, Department of Pediatrics, Dr Soetomo General Hospital, Faculty of Medicine, Universitas Airlangga, Surbaya, 60115, Indonesia. Hauptthemen laut MEDLINE: Hyperbilirubinemia, Neonatal, Jaundice, Neonatal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Airlangga.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal hyperbilirubinemia is one of the most common conditions for neonate inpatients. Indonesia faces a major challenge in which different guidelines regarding the management of this condition were present. This study aimed to compare the existing guidelines regarding prevention, diagnosis, treatment and monitoring in order to create the best recommendation for a new hyperbilirubinemia guideline in Indonesia.

Methods

Through an earlier survey regarding adherence to the neonatal hyperbilirubinemia guideline, we identified that three main guidelines are being used in Indonesia. These were developed by the Indonesian Pediatric Society (IPS), the Ministry of Health (MoH), and World Health Organization (WHO). In this study, we compared factors such as prevention, monitoring, methods for identifying, risk factors in the development of neonatal jaundice, risk factors that increase brain damage, and intervention treatment threshold in the existing guidelines to determine the best recommendations for a new guideline.

Results

The MoH and WHO guidelines allow screening and treatment of hyperbilirubinemia based on visual examination (VE) only. Compared with the MoH and WHO guidelines, risk assessment is comprehensively discussed in the IPS guideline. The MoH guideline recommends further examination of an icteric baby to ensure that the mother has enough milk without measuring the bilirubin level. The MoH guideline recommends referring the baby when it looks yellow on the soles and palms. The WHO and IPS guidelines recommend combining VE with an objective measurement of transcutaneous or serum bilirubin. The threshold to begin phototherapy in the WHO guideline is lower than the IPS guideline while the exchange transfusion threshold in both guidelines are comparably equal.

Conclusions

The MoH guideline is outdated. MoH and IPS guidelines are causing differences in approaches to the management hyperbilirubinemia. A new, uniform guideline is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbilirubinemia, NeonatalJaundice, NeonatalInfant, NewbornHumansChildIndonesiaPhototherapyBilirubin

Stichwörter der Autor:innen

LMICicterusneonatesrecommendations

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Neonatology Division, Department of Pediatrics, Dr Soetomo General Hospital, Faculty of Medicine, Universitas Airlangga, Surbaya, 60115, Indonesia.
  • Department of Pediatrics, Airlangga University Teaching Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya, 60115, Indonesia.
  • Medical Program, Faculty of Medicine, Universitas Airlangga, Surbaya, 60115, Indonesia.
  • Neonatal Intensive Care Unit, Harapan Kita Mother and Child Hospital, Jakarta, 11420, Indonesia.
  • Neonatology Division, Department of Pediatrics, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia.
  • Neonatology Division, Department of Child Health, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.

ORCID-Profile: Mahendra Tri Arif Sampurna, Visuddho Visuddho, Toto Wisnu Hendrarto, Kian Djien Liem

Förderung

  • Universitas Airlangga

Zitieren

APA

Sampurna, M. T. A., Pratama, D. C., Visuddho, V., Oktaviana, N., Putra, A. J. E., Zakiyah, R., Ahmad, J. M., Etika, R., Handayani, K. D., Utomo, M. T., Angelica, D., Ayuningtyas, W., Hendrarto, T. W., Rohsiswatmo, R., Wandita, S., Kaban, R. K., & Liem, K. D. (2023). A review of existing neonatal hyperbilirubinemia guidelines in Indonesia. F1000Research. https://doi.org/10.12688/f1000research.110550.2

Vancouver

Sampurna MTA, Pratama DC, Visuddho V, Oktaviana N, Putra AJE, Zakiyah R, et al. A review of existing neonatal hyperbilirubinemia guidelines in Indonesia. F1000Research. 2023. doi:10.12688/f1000research.110550.2

BibTeX
@article{Sampurna2023,
  author = {Sampurna, Mahendra Tri Arif and Pratama, Danny Chandra and Visuddho, Visuddho and Oktaviana, Novita and Putra, Achmad Januar Er and Zakiyah, Rahmi and Ahmad, Jordy Maulana and Etika, Risa and Handayani, Kartika Darma and Utomo, Martono Tri and Angelica, Dina and Ayuningtyas, Wurry and Hendrarto, Toto Wisnu and Rohsiswatmo, Rinawati and Wandita, Setya and Kaban, Risma Karina and Liem, Kian Djien},
  title = {A review of existing neonatal hyperbilirubinemia guidelines in Indonesia},
  journal = {F1000Research},
  year = {2023},
  doi = {10.12688/f1000research.110550.2}
}
Kostenlos starten →